National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: VI. Design of Clinical Trials Working Group Report
Open Access
- 31 May 2006
- journal article
- guideline
- Published by Elsevier in Transplantation and Cellular Therapy
- Vol. 12 (5) , 491-505
- https://doi.org/10.1016/j.bbmt.2006.03.004
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Ancillary Therapy and Supportive Care of Chronic Graft-versus-Host Disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: V. Ancillary Therapy and Supportive Care Working Group ReportTransplantation and Cellular Therapy, 2006
- Measuring Therapeutic Response in Chronic Graft-versus-Host Disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. Response Criteria Working Group ReportTransplantation and Cellular Therapy, 2006
- Histopathologic Diagnosis of Chronic Graft-versus-Host Disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: II. Pathology Working Group ReportPublished by Elsevier ,2006
- National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. Diagnosis and Staging Working Group ReportTransplantation and Cellular Therapy, 2005
- Duration of immunosuppressive treatment for chronic graft-versus-host diseaseBlood, 2004
- Chronic graft-versus-host diseaseTransplantation and Cellular Therapy, 2003
- Randomized clinical trial of thalidomide, cyclosporine, and prednisone versus cyclosporine and prednisone as initial therapy for chronic graft-versus-host diseaseTransplantation and Cellular Therapy, 2001
- Thalidomide for treatment of patients with chronic graft-versus-host diseaseBlood, 2000
- Outcomes of cancer treatment for technology assessment and cancer treatment guidelines. American Society of Clinical Oncology.Journal of Clinical Oncology, 1996
- Alternating-day cyclosporine and prednisone for treatment of high-risk chronic graft-v-host diseaseBlood, 1988